Seres Therapeutics, Inc.
USD7.65
-0.14 (-1.80%)
CEO
Richard N. Kender
IPO Date
2015-06-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.78
Prev. Close
$7.79
Day Low
$7.65
Day High
$7.83
52W Low
$5.31
52W High
$29.98
Market Cap
$0.07B
Volume
0.02M
| -0.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 253.5% | -31.7% | -4.43 | 1.78 | -1.6 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -2319.9% | -71.7% | 15.08 | 2.28 | -2.4 |
| 31 Dec 2021 | FY | 100.0% | -45.2% | -49.9% | -18.5% | 0.37 | 3.69 | -11.6 |
| 31 Dec 2020 | FY | -172.7% | -268.3% | -51.0% | -26.0% | 0.23 | 5.79 | -21.9 |
| 31 Dec 2019 | FY | 100.0% | -203.7% | 145.4% | -53.1% | -0.93 | 2.18 | -2.8 |
| 31 Dec 2018 | FY | -239.5% | -350.0% | 205.9% | -82.1% | -0.15 | 2.20 | -1.9 |
| 31 Dec 2017 | FY | -178.7% | -278.4% | -147.3% | -47.2% | 0.15 | 4.90 | -4.6 |
| 31 Dec 2016 | FY | -276.7% | -420.7% | -69.0% | -33.6% | 0.08 | 6.51 | -4.3 |
| -2.1 |
| 30 Sept 2025 | Q3 | -3704.0% | 2337.3% | 18.8% | 5.7% | 1.95 | 2.30 | 5.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -60.3% | -13.8% | 2.65 | 1.57 | -1.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 64.8% | 19.9% | 1.77 | 2.11 | 0.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -113.4% | -11.2% | 6.65 | 0.94 | -2.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 371.2% | 49.7% | 3.91 | 1.12 | 0.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 37.7% | -10.2% | -2.44 | 1.38 | -0.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 67.2% | -11.8% | -3.59 | 1.68 | -0.7 |
| 31 Dec 2023 | Q4 | 100.0% | -64450.0% | 92.0% | -11.5% | -4.43 | 1.78 | -1.1 |